Chin J Integr Med
-
Randomized Controlled Trial
Evaluation of transcutaneous electroacupoint stimulation with the train-of-four mode for preventing nausea and vomiting after laparoscopic cholecystectomy.
To evaluate the efficacy of transcutaneous electroacupoint stimulation with a train-of-four (TOF) mode for the prevention of postoperative nausea and vomiting (PONV) in the patients undergoing laparoscopic cholecystectomy. ⋯ Transcutaneous electroacupoint stimulation at P6 with the TOF mode could reduce the incidence and severity of nausea and vomiting with analgesic effects.
-
Randomized Controlled Trial
Effect of transcutaneous electrical acupoint stimulation on nausea and vomiting induced by patient controlled intravenous analgesia with tramadol.
To observe the effect of transcutaneous electrical acupoint stimulation (TEAS) on nausea and vomiting (N&V) induced by patient controlled intravenous analgesia (PCIA) with Tramadol. ⋯ TEAS could prevent N&V induced by PCIA with Tramadol.
-
Randomized Controlled Trial
Cardioprotection of Shenfu Injection against myocardial ischemia/reperfusion injury in open heart surgery.
To investigate the protective effect of Shenfu Injection (SFI) against myocardium ischemia/reperfusion injury (IRI) in mitral valve replacement (MVR) with cardiopulmonary bypass (CPB). ⋯ SFI had a certain protective effect against myocardium IRI. Moreover, better efficacy was seen with the administration of 1.5 mL/kg SFI into CPB priming fluid and pumping 1.5 mL/kg SFI via CPB as soon as the clamped aorta was unclamped.
-
Randomized Controlled Trial Comparative Study
Clinical research on nourishing yin and unblocking meridians recipe combined with opioid analgesics in cancer pain management.
To investigate the analgesic effects of Nourishing yin and Unblocking meridians Receipe (NUR) combined with opioid analgesics in managing cancer pain. ⋯ NUR combined with opioid analgesics in cancer pain management was more effective than opioid analgesics alone.
-
Randomized Controlled Trial Clinical Trial
Study on Yangxue Qingnao granule in treating chronic cerebrovascular insufficiency.
To observe the therapeutic effect of Yangxue Qingnao granule (YXQNG) in treating chronic cerebrovascular insufficiency (CCI) and its possible mechanism. ⋯ YXQNG could effectively improve CCI patients' vertigo and other clinical symptoms and increase the cerebral blood flow, lessen the vertigo incubation of model group rats, elevate model group rats' memory performance.